Literature DB >> 32788217

A soluble derivative of PrPC activates cell-signaling and regulates cell physiology through LRP1 and the NMDA receptor.

Elisabetta Mantuano1, Pardis Azmoon2, Michael A Banki2, Michael S Lam2, Christina J Sigurdson2, Steven L Gonias1.   

Abstract

Cellular prion protein (PrPC) is a widely expressed glycosylphosphatidylinositol-anchored membrane protein. Scrapie prion protein is a misfolded and aggregated form of PrPC responsible for prion-induced neurodegenerative diseases. Understanding the function of the nonpathogenic PrPC monomer is an important objective. PrPC may be shed from the cell surface to generate soluble derivatives. Herein, we studied a recombinant derivative of PrPC (soluble cellular prion protein, S-PrP) that corresponds closely in sequence to a soluble form of PrPC shed from the cell surface by proteases in the A Disintegrin And Metalloprotease (ADAM) family. S-PrP activated cell-signaling in PC12 and N2a cells. TrkA was transactivated by Src family kinases and extracellular signal-regulated kinase 1/2 was activated downstream of Trk receptors. These cell-signaling events were dependent on the N-methyl-d-aspartate receptor (NMDA-R) and low-density lipoprotein receptor-related protein-1 (LRP1), which functioned as a cell-signaling receptor system in lipid rafts. Membrane-anchored PrPC and neural cell adhesion molecule were not required for S-PrP-initiated cell-signaling. S-PrP promoted PC12 cell neurite outgrowth. This response required the NMDA-R, LRP1, Src family kinases, and Trk receptors. In Schwann cells, S-PrP interacted with the LRP1/NMDA-R system to activate extracellular signal-regulated kinase 1/2 and promote cell migration. The effects of S-PrP on PC12 cell neurite outgrowth and Schwann cell migration were similar to those caused by other proteins that engage the LRP1/NMDA-R system, including activated α2-macroglobulin and tissue-type plasminogen activator. Collectively, these results demonstrate that shed forms of PrPC may exhibit important biological activities in the central nervous system and the peripheral nervous system by serving as ligands for the LRP1/NMDA-R system.
© 2020 Mantuano et al.

Entities:  

Keywords:  ERK1/2; LRP1; N-methyl-d-aspartate receptor (NMDA receptor; NMDA-R); PC12 cells; PrPC; Schwann cells; TRK1-transforming tyrosine kinase protein (TrkA); cell-signaling; extracellular signal–regulated kinase (ERK); lipid raft; neurite outgrowth

Mesh:

Substances:

Year:  2020        PMID: 32788217      PMCID: PMC7549038          DOI: 10.1074/jbc.RA120.013779

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.

Authors:  Géraldine Liot; Benoit D Roussel; Nathalie Lebeurrier; Karim Benchenane; José P López-Atalaya; Denis Vivien; Carine Ali
Journal:  J Neurochem       Date:  2006-06-27       Impact factor: 5.372

2.  The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury.

Authors:  W Marie Campana; Xiaoqing Li; Nikola Dragojlovic; Julie Janes; Alban Gaultier; Steven L Gonias
Journal:  J Neurosci       Date:  2006-10-25       Impact factor: 6.167

3.  Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons.

Authors:  D W Choi; S Peters; V Viseskul
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

4.  Glycosylation differences between the normal and pathogenic prion protein isoforms.

Authors:  P M Rudd; T Endo; C Colominas; D Groth; S F Wheeler; D J Harvey; M R Wormald; H Serban; S B Prusiner; A Kobata; R A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  Prion protein protects human neurons against Bax-mediated apoptosis.

Authors:  Y Bounhar; Y Zhang; C G Goodyer; A LeBlanc
Journal:  J Biol Chem       Date:  2001-08-24       Impact factor: 5.157

6.  Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.

Authors:  Petra May; Astrid Rohlmann; Hans H Bock; Kai Zurhove; Jamey D Marth; Eike D Schomburg; Jeffrey L Noebels; Uwe Beffert; J David Sweatt; Edwin J Weeber; Joachim Herz
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

Review 7.  Molecular mechanisms of prion pathogenesis.

Authors:  Adriano Aguzzi; Christina Sigurdson; Mathias Heikenwaelder
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor-related protein 1 requires lysines 80, 88, and 207.

Authors:  Mary Migliorini; Shih-Hon Li; Anqi Zhou; Cory D Emal; Daniel A Lawrence; Dudley K Strickland
Journal:  J Biol Chem       Date:  2019-12-02       Impact factor: 5.157

9.  A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.

Authors:  Alex J McDonald; Jessie P Dibble; Eric G B Evans; Glenn L Millhauser
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

10.  The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes.

Authors:  Magdalini Polymenidou; Rita Moos; Mike Scott; Christina Sigurdson; Yong-Zhong Shi; Bill Yajima; Iva Hafner-Bratkovic; Roman Jerala; Simone Hornemann; Kurt Wuthrich; Anne Bellon; Martin Vey; Graciela Garen; Michael N G James; Nat Kav; Adriano Aguzzi
Journal:  PLoS One       Date:  2008-12-08       Impact factor: 3.240

View more
  7 in total

Review 1.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

2.  A Soluble PrPC Derivative and Membrane-Anchored PrPC in Extracellular Vesicles Attenuate Innate Immunity by Engaging the NMDA-R/LRP1 Receptor Complex.

Authors:  Elisabetta Mantuano; Pardis Azmoon; Michael A Banki; Christina J Sigurdson; Wendy M Campana; Steven L Gonias
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.422

3.  The LRP1/CD91 ligands, tissue-type plasminogen activator, α2-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling.

Authors:  Elisabetta Mantuano; Pardis Azmoon; Michael A Banki; Cory B Gunner; Steven L Gonias
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Mohsin Shafiq; Karl Frontzek; Julia Bär; Amulya N Shrivastava; Markus Damme; Feizhi Song; Alexander Schwarz; Stefano Da Vela; Tania Massignan; Sebastian Jung; Angela Correia; Matthias Schmitz; Berta Puig; Simone Hornemann; Inga Zerr; Jörg Tatzelt; Emiliano Biasini; Paul Saftig; Michaela Schweizer; Dmitri Svergun; Ladan Amin; Federica Mazzola; Luca Varani; Simrika Thapa; Sabine Gilch; Hermann Schätzl; David A Harris; Antoine Triller; Marina Mikhaylova; Adriano Aguzzi; Hermann C Altmeppen; Markus Glatzel
Journal:  Sci Adv       Date:  2021-11-24       Impact factor: 14.136

Review 5.  Prion Protein: The Molecule of Many Forms and Faces.

Authors:  Valerija Kovač; Vladka Čurin Šerbec
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

6.  Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interference.

Authors:  Daniel Heinzer; Merve Avar; Daniel Patrick Pease; Ashutosh Dhingra; Jiang-An Yin; Elke Schaper; Berre Doğançay; Marc Emmenegger; Anna Spinelli; Kevin Maggi; Andra Chincisan; Simon Mead; Simone Hornemann; Peter Heutink; Adriano Aguzzi
Journal:  PLoS Pathog       Date:  2021-10-27       Impact factor: 6.823

Review 7.  Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.

Authors:  Shuang Chen; Da Xu; Liu Fan; Zhi Fang; Xiufeng Wang; Man Li
Journal:  Front Mol Neurosci       Date:  2022-01-07       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.